Delivery Order SPE2DB25D3006-SPE2DB25FXKPL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,326.72 to AmerisourceBergen Drug Corp for the supply of Estrogen-Methyltestosterone tablets (100 count) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitive award utilizes firm fixed pricing with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,071.28 to AmerisourceBergen Drug Corp for the supply of Estrogen-Methyltestosterone tablets (100 count) on September 10, 2025, with an ultimate completion date of September 11, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $1,584.51 to AmerisourceBergen Drug Corp for the supply of Estrogen-Methyltestosterone tablets (100 count) on April 24, 2025, with completion scheduled for April 25, 2025. This non-set-aside contract represents a firm fixed price delivery order executed under competitive procurement procedures. The award leverages AmerisourceBergen's extensive pharmaceutical distribution capabilities and established relationship with the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $1,239.43 to AmerisourceBergen Drug Corp for the supply of Estrogen-Methyltestosterone tablets (100-count units) on July 24, 2025, with completion scheduled for July 25, 2025. This competitively awarded, firm fixed-price contract was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The order represents a child contract under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $1,454.40 to AmerisourceBergen Drug Corp for Estrogen-Methyltestosterone tablets (100 count) on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,161.18 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Estrogen-Methyltestosterone tablets (100 count). This firm fixed price contract, with an ultimate completion date of August 7, 2025, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation and will be performed at the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Estrogen-Methyltestosterone tablets (100 count) with a ceiling value of $3,170.48. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 18, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,317.41 to AmerisourceBergen Drug Corp for Estrogen-Methyltestosterone tablets (100-count) with a firm fixed price structure. This non-set-aside contract was awarded on August 19, 2025, with an ultimate completion date of August 20, 2025. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency Troop Support Medical awarded a $395,620 delivery order to Amerisourcebergen Drug Corporation for the supply of 100 units of Estrogen-Methyltestos H.S. tablets. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The firm fixed price order has a period of performance from July 24, 2023 through July 25, 2023 to fulfill the Defense Logistics Agency's requirements for this pharmaceutical product. No major subcontractors or set...
- The Defense Logistics Agency awarded a $915.72 delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division to provide 100 units of Estrogen-Methyltestos F.S. tablets from September 20th through September 21st, 2023. The prime contractor Amerisourcebergen Drug Corp Corporate Office Division will deliver the pharmaceutical products to the place of performance in Conshohocken, Pennsylvania under a firm fixed price arrangement. No major subcontractors or set aside designations...
- SPE2DB25D3006Indefinite Delivery Contract
- SPE2DB25D3006-SPE2DB25FXKPLDelivery Order
The Defense Logistics Agency awarded a $1,940.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for estrogen-methyltestosterone tablets (100-count) on September 25, 2025, with completion scheduled for September 26, 2025. This non-set-aside contract was competitively awarded to the major pharmaceutical distributor and reflects routine medical supply procurement for military healthcare needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor in the federal medical supply chain and holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. This delivery order is issued under AmerisourceBergen Drug Corp's broader SPE2DX prime IDC, which authorizes the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs. The contract vehicle enables the company to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains. As a child contract under this larger indefinite delivery vehicle, the current award demonstrates the company's ongoing role in fulfilling routine pharmaceutical procurement requirements within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 9/25/25 |